Is transient elastography a useful tool for screening liver disease?

Table 2 Diagnostic performance of TE in the diagnosis of significant fibrosis

	Oliveri[14]	Marcellin[13]	Castera[35]	Ziol[15]	Fraquelli[3]	Corpechot[18]	Kelleher[16]	Yoneda[17]
Patients	268	170	183	251	200	95	129	67
F2 or higher (%)	69	50	74	65	50	60	50	49
Etiology	HBV	HBV	HCV	HCV	80% HCV	PBC/PSC	Nafld	Nafld
Cut Off (KPa)	7.5	7.2	7.1	8.8	7.9	7.3	8.7	6.6
Sensitivity (%)	93	70	67	56	72	84	81	82
Specificity (%)	88	83	89	91	84	87	78	81
AUROC	0.96	0.81	0.83	0.79	0.86	0.92	0.86	0.87